111 Financials
YI Stock | USD 0.61 0.01 1.61% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 1.02 | 1.0686 |
|
|
Investors should never underestimate 111's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor 111's cash flow, debt, and profitability to make informed and accurate decisions about investing in 111 Inc.
Net Income |
|
111 | Select Account or Indicator |
Understanding current and past 111 Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of 111's financial statements are interrelated, with each one affecting the others. For example, an increase in 111's assets may result in an increase in income on the income statement.
111 Stock Summary
111 competes with Walgreens Boots, PetMed Express, China Jo, Leafly Holdings, and High Tide. 111, Inc. operates an integrated online and offline platform in the healthcare market in the Peoples Republic of China. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the Peoples Republic of China. 111 Inc operates under Pharmaceutical Retailers classification in the United States and is traded on NASDAQ Exchange. It employs 2114 people.Specialization | Consumer Staples, Consumer Staples Distribution & Retail |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US68247Q1022 |
CUSIP | 68247Q102 |
Location | China |
Business Address | No295 ZuChongZhi Road, |
Sector | Consumer Staples Distribution & Retail |
Industry | Consumer Staples |
Benchmark | Dow Jones Industrial |
Website | corporate.111.com.cn |
Phone | 86 21 2053 6666 |
Currency | USD - US Dollar |
111 Key Financial Ratios
Return On Equity | -0.66 | ||||
Profit Margin | (0.02) % | ||||
Operating Margin | 0 % | ||||
Price To Sales | 0 X | ||||
Revenue | 14.95 B |
111 Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.6B | 3.0B | 3.1B | 3.5B | 3.1B | 2.4B | |
Other Current Liab | 159.2M | 279.8M | 243.7M | 355.2M | 575.4M | 604.1M | |
Other Liab | 8.1M | 5.9M | 3.7M | 1.5M | 1.8M | 1.7M | |
Net Tangible Assets | 1.2B | 768.6M | 350.9M | (178.2M) | (205.0M) | (194.7M) | |
Net Debt | (461.7M) | (898.0M) | (236.1M) | (394.2M) | (160.3M) | (168.3M) | |
Retained Earnings | (1.9B) | (2.3B) | (3.0B) | (3.4B) | (3.8B) | (3.6B) | |
Accounts Payable | 416.5M | 1.1B | 1.3B | 1.8B | 1.6B | 911.5M | |
Cash | 613.7M | 1.2B | 661.4M | 673.7M | 603.5M | 706.3M | |
Other Assets | 3.4M | 3.0M | 5.1M | 22.1M | 25.4M | 26.7M | |
Net Receivables | 88.8M | 175.7M | 495.2M | 600.5M | 647.5M | 679.9M | |
Inventory | 486.3M | 766.5M | 1.1B | 1.5B | 1.4B | 795.0M | |
Other Current Assets | 7.0M | 440.7M | 341.5M | 256.9M | 212.8M | 175.9M | |
Total Liab | 836.4M | 1.7B | 2.3B | 2.8B | 2.8B | 1.6B | |
Short Long Term Debt | 95.1M | 229.3M | 259.7M | 179.0M | 338.1M | 355.0M | |
Total Current Assets | 1.5B | 2.9B | 2.8B | 3.2B | 2.9B | 2.3B | |
Short Term Debt | 95.1M | 267.0M | 325.4M | 243.7M | 380.6M | 193.6M | |
Intangible Assets | 8.0M | 920K | 4.9M | 3.3M | 2.3M | 3.4M | |
Net Invested Capital | 871.7M | 586.7M | 86.3M | (235.6M) | (245.4M) | (233.1M) |
111 Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Net Interest Income | 1.2M | (2.5M) | 4.3M | (5.3M) | (8.7M) | (8.3M) | |
Interest Income | 4.8M | 6.3M | 9.8M | 8.1M | 8.6M | 6.6M | |
Interest Expense | 3.6M | 8.8M | 5.5M | 13.4M | 20.1M | 21.1M | |
Total Revenue | 4.0B | 8.2B | 12.4B | 13.5B | 14.9B | 7.8B | |
Gross Profit | 165.2M | 365.8M | 621.1M | 840.0M | 448.4M | 373.1M | |
Operating Income | (493.5M) | (473.3M) | (642.1M) | (371.0M) | (350.1M) | (367.6M) | |
Ebit | (493.5M) | (473.3M) | (642.1M) | (371.0M) | (333.0M) | (349.7M) | |
Research Development | 61.9M | 92.1M | 189.3M | 139.5M | 124.3M | 83.5M | |
Ebitda | (487.9M) | (459.3M) | (614.9M) | (330.2M) | (311.3M) | (326.8M) | |
Cost Of Revenue | 3.8B | 7.8B | 11.8B | 12.7B | 14.5B | 7.4B | |
Income Before Tax | (501.8M) | (467.1M) | (621.0M) | (376.1M) | (353.2M) | (370.8M) | |
Net Income | (492.4M) | (459.0M) | (663.0M) | (408.5M) | (392.7M) | (412.3M) | |
Income Tax Expense | (9.4M) | (8.1M) | 41.9M | 32.4M | 251K | 238.5K | |
Minority Interest | (2.7M) | 973.2M | (48.8M) | (40.8M) | (44.5M) | (42.2M) |
111 Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change To Inventory | (276.2M) | 24.2M | (400.6M) | 28.5M | 59.6M | 62.6M | |
Investments | 262.1M | (324.7M) | 60.1M | (47.2M) | (26.3M) | (27.6M) | |
Change In Cash | (156.0M) | 620.8M | (557.9M) | (43.9M) | (93.2M) | (88.6M) | |
Free Cash Flow | (534.8M) | (142.3M) | (704.6M) | (54.7M) | (457.1M) | (479.9M) | |
Depreciation | 11.7M | 14.0M | 27.2M | 40.8M | 21.8M | 21.1M | |
Other Non Cash Items | 25.4M | 334.8M | 89.8M | (209.0M) | 82.0M | 42.8M | |
Capital Expenditures | 24.6M | 25.5M | 62.7M | 31.6M | 9.8M | 9.3M | |
Net Income | (501.8M) | (456.5M) | (621.0M) | (376.1M) | (353.4M) | (371.1M) | |
End Period Cash Flow | 697.7M | 1.3B | 760.7M | 716.8M | 623.5M | 757.9M | |
Change To Netincome | 39.7M | 79.6M | 339.8M | 27.9M | 32.1M | 30.5M |
111 Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining 111's current stock value. Our valuation model uses many indicators to compare 111 value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across 111 competition to find correlations between indicators driving 111's intrinsic value. More Info.111 Inc is rated third in return on equity category among its peers. It is rated third in return on asset category among its peers . As of now, 111's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the 111's earnings, one of the primary drivers of an investment's value.111 Inc Systematic Risk
111's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. 111 volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on 111 Inc correlated with the market. If Beta is less than 0 111 generally moves in the opposite direction as compared to the market. If 111 Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one 111 Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of 111 is generally in the same direction as the market. If Beta > 1 111 moves generally in the same direction as, but more than the movement of the benchmark.
111 Thematic Clasifications
111 Inc is part of Retail investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Retail industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Retail industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Retail | View |
Today, most investors in 111 Stock are looking for potential investment opportunities by analyzing not only static indicators but also various 111's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of 111 growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
111 November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of 111 help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of 111 Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of 111 Inc based on widely used predictive technical indicators. In general, we focus on analyzing 111 Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build 111's daily price indicators and compare them against related drivers.
Information Ratio | (0.09) | |||
Maximum Drawdown | 29.86 | |||
Value At Risk | (9.52) | |||
Potential Upside | 14.42 |
Complementary Tools for 111 Stock analysis
When running 111's price analysis, check to measure 111's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 111 is operating at the current time. Most of 111's value examination focuses on studying past and present price action to predict the probability of 111's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 111's price. Additionally, you may evaluate how the addition of 111 to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |